Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heart failure: an update from the last years and a look at the near future
Mauro Riccardi, Antonio Maria Sammartino, Massimo Piepoli, et al.
ESC Heart Failure (2022) Vol. 9, Iss. 6, pp. 3667-3693
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

2024 update in heart failure
Alberto Beghini, Antonio Maria Sammartino, Z. Papp, et al.
ESC Heart Failure (2024)
Open Access | Times Cited: 31
Optimisation of treatments for heart failure with reduced ejection fraction in routine practice: a position statement from a panel of experts
Nicolas Girerd, Christophe Leclercq, Olivier Hanon, et al.
Revista Española de Cardiología (English Edition) (2023) Vol. 76, Iss. 10, pp. 813-820
Open Access | Times Cited: 31
Functional Mitral Regurgitation and Heart Failure With Preserved Ejection Fraction: Clinical Implications and Management
Mauro Riccardi, Maja Čikeš, Marianna Adamo, et al.
Journal of Cardiac Failure (2024) Vol. 30, Iss. 7, pp. 929-939
Open Access | Times Cited: 8
Prognostic Implications of Sex in Patients With Heart Failure With Mildly Reduced Ejection Fraction: Results From a Large‐Scaled Registry
Marielen Reinhardt, Michael Behnes, Kathrin Weidner, et al.
Journal of the American Heart Association (2025) Vol. 14, Iss. 2
Open Access | Times Cited: 1
Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trials
Daniela Tomasoni, Giovanni Battista Bonfioli, Alberto Aimo, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 21
Soluble ST2 in Heart Failure: A Clinical Role beyond B-Type Natriuretic Peptide
Mauro Riccardi, Peder L. Myhre, Thomas A. Zelniker, et al.
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 11, pp. 468-468
Open Access | Times Cited: 14
2023 focused update of the 2021 ESC heart failure guidelines: Key messages for clinical practice
Daniela Tomasoni, Antonio Cannatà, Marianna Adamo, et al.
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 4
Closed Access | Times Cited: 4
High mRNA Expression of 24 Dehydrocholesterol Reductase (DHCR24) in the Treatment of Doxorubicin-Induced Heart Failure in Rats
Rui Zhang, Siyuan Peng, Xuejuan Zhang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 312-312
Open Access
LYVE1 and IL1RL1 are mitochondrial permeability transition-driven necrosis-related genes in heart failure
Zihe Zheng, Wei Wang, Ming Huang, et al.
The International Journal of Biochemistry & Cell Biology (2025), pp. 106738-106738
Closed Access
Development and validation of a prediction model based on machine learning algorithms for predicting the risk of heart failure in middle‐aged and older US people with prediabetes or diabetes
Yicheng Wang, Riting Hou, Binghang Ni, et al.
Clinical Cardiology (2023) Vol. 46, Iss. 10, pp. 1234-1243
Open Access | Times Cited: 9
An updated review of experimental rodent models of pulmonary hypertension and left heart disease
Magdalena Jasińska-Stroschein
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 3
Multi-modal heart failure risk estimation based on short ECG and sampled long-term HRV
Sergio González, Abel Ko-Chun Yi, Wan‐Ting Hsieh, et al.
Information Fusion (2024) Vol. 107, pp. 102337-102337
Open Access | Times Cited: 3
Distribution and prognostic impact of different heart failure etiologies in patients with heart failure with mildly reduced ejection fraction
Tobias Schupp, Alexander Schmitt, Felix Lau, et al.
European Journal of Internal Medicine (2024)
Open Access | Times Cited: 3
Evaluating the link between DIO3-FA27 promoter methylation, biochemical indices, and heart failure progression
Qi Yan, Xiangchao Meng, Jing Li, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
The role of body composition in left ventricular remodeling, reverse remodeling, and clinical outcomes for heart failure with mildly reduced ejection fraction: more knowledge to the “obesity paradox”
Kang Fu, Youran Dong, Zhiyuan Wang, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction?
Mauro Riccardi, Antonio Maria Sammartino, Marianna Adamo, et al.
Heart Failure Reviews (2023) Vol. 28, Iss. 5, pp. 1141-1149
Closed Access | Times Cited: 5
Six-Month Pilot Testing of a Digital Health Tool to Support Effective Self-Care in People With Heart Failure: Mixed Methods Study
Alison Keogh, Carol Brennan, William Johnston, et al.
JMIR Formative Research (2023) Vol. 8, pp. e52442-e52442
Open Access | Times Cited: 5
A Single-Center, Randomized Controlled Trial to Test the Efficacy of Nurse-Led Motivational Interviewing for Enhancing Self-Care in Adults with Heart Failure
Federica Dellafiore, Greta Ghizzardi, Ercole Vellone, et al.
Healthcare (2023) Vol. 11, Iss. 5, pp. 773-773
Open Access | Times Cited: 4
Relation between Systemic Inflammatory Index (SII) and Hair Trace Elements, Metals and Metalloids Concentration in Epicardial Coronary Artery Disease—Preliminary Report
Tomasz Urbanowicz, Anetta Hańć, Anna Olasińska‐Wiśniewska, et al.
Reviews in Cardiovascular Medicine (2023) Vol. 24, Iss. 12, pp. 358-358
Open Access | Times Cited: 4
New Therapeutics for Heart Failure Worsening: Focus on Vericiguat
Patrizia Russo, Laura Vitiello, Francesca Milani, et al.
(2024)
Open Access | Times Cited: 1
Obesity and 1-year all-cause survival of adult intensive care patients with heart failure: data from the MIMIC-IV.
Fei Xu, Cheng Zhang
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Risk scores: A valid tool for reducing mortality in cardiogenic shock?
Gloria Palamara, Alberto Aimo, Daniela Tomasoni
ESC Heart Failure (2024) Vol. 11, Iss. 6, pp. 3466-3469
Open Access | Times Cited: 1
Sodium glucose co-transporter 2 inhibitors and quality of life in patients with heart failure: a comprehensive systematic review and meta-analysis of randomized controlled trials
Chiara Oriecuia, Daniela Tomasoni, Isabella Sala, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2023) Vol. 10, Iss. 2, pp. 147-157
Closed Access | Times Cited: 3
Prognostic impact of chronic obstructive pulmonary disease in patients with heart failure with mildly reduced ejection fraction
Felix Lau, Tobias Schupp, Alexander Schmitt, et al.
Respiratory Medicine (2024) Vol. 223, pp. 107536-107536
Open Access
Page 1 - Next Page

Scroll to top